MEDS
TPET
SCNX

Michael L. Peterson

Known title: DirectorCIK: 0001293970

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 2, 2026

MEDS hits $1M monthly Corexa revenue, unveils health app. DataMeds AI reported that its Corexa Pharmacy generated over $1 million in revenue for the month, reflecting a 66% increase in sales. The company also introduced the Health Lives Here app, which targets GLP‑1 telehealth and pharmacy services. The announcements coincided with a reported rise in the stock price following the app launch.

this person other insiders at MEDS

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 2, 2026

Trio Petroleum Announces Lloydminster Acquisition. Trio Petroleum has announced the acquisition of Lloydminster assets, citing potential for production growth through multilateral oil well and workover opportunities. This strategic move aims to expand the company's operational footprint in a key Canadian oil region. The stock currently trades within a wide 52-week range, reflecting the significant volatility often associated with smaller energy exploration companies.

this person other insiders at TPET

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

SCNX Shares Drop 19% After Hours Amid Reverse Split. SCNX shares fell 19% in after‑hours trading after the company announced a reverse stock split. The reverse split will consolidate shares, potentially raising the share price but also reducing the number of shares outstanding. The drop comes while the stock sits near its 12‑month low and has a very low RSI, indicating a possible oversold condition. The reverse split may be a move to meet listing requirements and support future trading.

this person other insiders at SCNX

Transaction History

MEDS▲ Buy$180K
TPET▲ Buy—
TPET▲ Buy—
SCNX▲ Buy$0
SCNX▼ Sell$4K
SCNX▼ Sell$0
SCNX▼ Sell$4K
SCNX▲ Buy$55K
SCNX▼ Sell$9K
SCNX▲ Buy$55K

We use analytics to understand how market-wall is used. No personal data is sold.